Document Classification

Section Type: METHODS

Text: Randomized controlled clinical trial where eligible patients were randomly allocated to : (i) 2RE (3) HZ (3) (alt) / 4RH (2) (split I) : rifampicin plus ethambutol given on one day and isoniazid plus pyrazinamide the next day for first 2 months followed by rifampicin plus isoniazid twice weekly for 4 months, or (ii) 3RE (3) HZ (3) (alt) / 3RH (2) (split II) : similar to regimen 1, except duration was 3 months in each phase, or (iii) 2REHZ (3) / 4RH (2) (control) : rifampicin, isoniazid, ethambutol and pyrazinamide, given thrice weekly for 2 months followed by isoniazid and rifampicin twice weekly for 4 months.